Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession
Jon Green
•As a board of director for ERBI (Cambridge, UK) for many years, the current vice president of business operations for MedImmune (Gaithersburg, MD), Jon Green, will become the new Chairman for the organization.
Tammy Miller
•Now the new vice president of project management for ERT (Philadelphia, PA), Tammy Miller will hold the responsibility of globally implementing and delivering the company's project assurance methodology, which will include developing and executing strategic plans to enhance customer service.
Don Berg
•With the promotion of Don Berg to president of Clinical Supplies Management (Fargo, ND), who will now manage operations, sales, and finance divisions of the company, the role of chief executive officer has been given to Gerald Finken, who will now focus on business strategies and growth opportunities, including development of on-demand packaging and labeling.
Gerald Finken
•Appointed to the position of CRF's (Lansdale, PA) clinical advisor, Nadina Jose, MD, will gain the responsibility of providing clinical insight and site experience to clients and internal staff, as well as provide therapeutic training, industry white paper leadership, speak at industry conferences, and represent the company's special interest groups.
• BASi (West Lafayette, IN) has expanded its business development team in the United States with Don Hawker now representing the company in Canada and the Western United States, including California, Oregon, Washington, Idaho, Nevada, Utah, Montana, Arizona, and Wyoming.
•The former founding executive, president, and chief scientific officer of Quintiles Laboratories (Westmont, IL), Frank Morrow, PhD, is now the chief operating officer of LabConnect (Seattle, WA).
Professor So Iwata, an Imperial College London scientist, accepting his £2 million Diamond Fellowship from the Biotechnology and Biological Sciences Research Council.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.